Log in
Enquire now
Umoja Biopharma

Umoja Biopharma

Umoja Biopharma is a biopharmaceutical company developing next-generation immunotherapies intended to combat cancer.

OverviewStructured DataIssuesContributors

Contents

umoja-biopharma.com
Is a
Organization
Organization
Company
Company

Company attributes

Industry
Cell therapy
Cell therapy
Biomedical engineering
Biomedical engineering
Healthcare
Healthcare
Regenerative medicine
Regenerative medicine
Biotechnology
Biotechnology
Stem cell
Stem cell
Pharmaceutical industry
Pharmaceutical industry
Tissue engineering
Tissue engineering
...
Location
Seattle
Seattle
B2X
B2B
B2B
CEO
‌
Andrew Scharenberg, MD
Founder
‌
Andrew Scharenberg, MD
Number of Employees (Ranges)
51 – 200
Email Address
info@umoja-biopharma.com
Full Address
1920 Terry Avenue, Seattle, WA 98101, US
Investors
MPM Capital
MPM Capital
Qiming Venture Partners (USA)
Qiming Venture Partners (USA)
Founded Date
2019
Total Funding Amount (USD)
262,969,286
Latest Funding Round Date
June 2021
CTO
‌
Ryan Crisman, PhD
CFO
‌
Britton Russell
Latest Funding Type
Series A
Series A
COO
‌
David Fontana, PhD
Country
United States
United States

Other attributes

Company Operating Status
Active
Public/Private
Private
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Umoja Biopharma

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us